Phoenix, AZ, October 24, 2005-The International Genomics Consortium's (IGC) Expression Project for Oncology (expO) today announced that it has collected its 1,000th frozen cancer specimen, which ...

PHILADELPHIA--(BUSINESS WIRE)--The National Disease Research Interchange (NDRI), in collaboration with Children’s Hospital of Philadelphia (CHOP), the University of Maryland’s Medicine Department of ...

Expressing recombinant proteins is one of the most challenging, but at the same time most important tasks in the life sciences. Irrespective of the specific protein and the downstream applications, ...

The success of recombinant protein expression depends on selecting the right protein expression system. Target protein properties, intended applications, protein yield, as well as cost, must all be ...

Researchers and companies are devising promising approaches to circumvent limitations of existing transfection technologies. Ongoing challenges, particularly with regard to high-quality recombinant ...

PHILADELPHIA--(BUSINESS WIRE)--The National Disease Research Interchange (NDRI) is pleased to announce its recovery network partners for the developmental Genotype-Tissue Expression (dGTEx) project.

Differences in the expression and splicing of genes are important drivers of trait variation both within and between species. In humans, many of the foundational studies exploring this variation have ...

Gene dysregulation is a hallmark of disease, driving pathogenic phenotypes and poor patient outcomes. RNA binding proteins are often important human gene effectors, controlling RNA synthesis, ...